These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 21633402

  • 1. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.
    Onat A, Can G, Örnek E, Çiçek G, Ayhan E, Doğan Y.
    Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402
    [Abstract] [Full Text] [Related]

  • 2. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
    Onat A, Hergenç G, Can G, Kaya Z, Yüksel H.
    Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
    [Abstract] [Full Text] [Related]

  • 3. Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men.
    Ryu S, Chang Y, Woo HY, Yoo SH, Choi NK, Lee WY, Kim I, Song J.
    Metabolism; 2010 May; 59(5):683-9. PubMed ID: 19922966
    [Abstract] [Full Text] [Related]

  • 4. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
    Onat A, Hergenç G, Can G, Küçükdurmaz Z.
    Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142
    [Abstract] [Full Text] [Related]

  • 5. Serum uric acid is a determinant of metabolic syndrome in a population-based study.
    Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Sari I, Yazici M, Keleş I.
    Am J Hypertens; 2006 Oct; 19(10):1055-62. PubMed ID: 17027827
    [Abstract] [Full Text] [Related]

  • 6. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
    Onat A, Can G, Hergenç G.
    Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
    [Abstract] [Full Text] [Related]

  • 7. Serum gamma glutamyltransferase as a marker of metabolic syndrome and coronary disease likelihood in nondiabetic middle-aged and elderly adults.
    Onat A, Hergenç G, Karabulut A, Türkmen S, Doğan Y, Uyarel H, Can G, Sansoy V.
    Prev Med; 2006 Aug; 43(2):136-9. PubMed ID: 16714057
    [Abstract] [Full Text] [Related]

  • 8. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
    Onat A, Uzunlar B, Hergenç G, Yazici M, Sari I, Uyarel H, Can G, Sansoy V.
    Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
    [Abstract] [Full Text] [Related]

  • 9. Relationship of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes.
    Zoppini G, Targher G, Trombetta M, Lippi G, Muggeo M.
    Obesity (Silver Spring); 2009 Feb; 17(2):370-4. PubMed ID: 19057528
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort.
    André P, Balkau B, Vol S, Charles MA, Eschwège E, DESIR Study Group.
    Diabetes Care; 2007 Sep; 30(9):2355-61. PubMed ID: 17586745
    [Abstract] [Full Text] [Related]

  • 12. gamma-Glutamyltransferase, obesity, physical activity, and the metabolic syndrome in indigenous Australian adults.
    Li M, Campbell S, McDermott R.
    Obesity (Silver Spring); 2009 Apr; 17(4):809-13. PubMed ID: 19148121
    [Abstract] [Full Text] [Related]

  • 13. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
    Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB, Vasan RS.
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
    [Abstract] [Full Text] [Related]

  • 14. Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population.
    Meisinger C, Löwel H, Heier M, Schneider A, Thorand B, KORA Study Group.
    J Intern Med; 2005 Dec; 258(6):527-35. PubMed ID: 16313476
    [Abstract] [Full Text] [Related]

  • 15. Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort.
    André P, Balkau B, Born C, Charles MA, Eschwège E, D.E.S.I.R. study group.
    Diabetologia; 2006 Nov; 49(11):2599-603. PubMed ID: 16969645
    [Abstract] [Full Text] [Related]

  • 16. Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.
    Lim HS, Lip GY, Beevers DG, Blann AD.
    Eur J Clin Invest; 2005 May; 35(5):324-9. PubMed ID: 15860044
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The association of plasma cysteine and gamma-glutamyltransferase with BMI and obesity.
    Elshorbagy AK, Refsum H, Smith AD, Graham IM.
    Obesity (Silver Spring); 2009 Jul; 17(7):1435-40. PubMed ID: 19214177
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women.
    Lee DH, Silventoinen K, Hu G, Jacobs DR, Jousilahti P, Sundvall J, Tuomilehto J.
    Eur Heart J; 2006 Sep; 27(18):2170-6. PubMed ID: 16772340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.